May 23, 2017 – Results now published in the European Heart Journal show Biotronik Home Monitoring reduces the risk of all-cause mortality in ICD patients after one year by 38 percent. The TRUECOIN study also found a 36 percent reduction in the combined risk of all-cause mortality and hospitalization for worsening heart failure.[1]

W. L. Gore & Associates (Gore) announced positive results from its REDUCE Study assessing closure of patent foramen ovale (PFO) for the reduction of recurrent ischemic stroke and new brain infarct. The data were shared May 16 at the European Stroke Organisation Conference (ESOC) in Prague, Czech Republic. Gore plans to submit the positive data to the U.S. Food and Drug Administration (FDA) to seek a PFO indication for the Gore Cardioform Septal Occluder by year-end 2017.

May 24, 2017 — Philips recently announced the results from a global study indicating that automated three-dimensional echocardiographic (3DE) analysis of left-heart chambers is an accurate alternative to conventional manual methodology. This multicenter study assessed Philips HeartModel A.I.

Death in patients with heart failure is inversely related to the wealth of the country they live in, according to late breaking results from the INTERCHF study presented at Heart Failure 2017 and the 4th World Congress on Acute Heart Failure, April 29-May 2 in Paris, France. Death rates in India and Africa were three to four times higher than those documented in Western countries.

May 23, 2017 — The American Society of Echocardiography (ASE) will host its 28th Annual Scientific Sessions, June 2-6, 2017, at the Baltimore Convention Center. The program includes learning opportunities from the basics of clinical imaging, to the most sophisticated advances in microbubble gene delivery, to the determination of the best use of echocardiography in value-driven healthcare. The aim is to translate core concepts and new ideas into applicable frameworks.

Shockwave Medical announced last week CE Mark for the company’s Coronary Lithoplasty System for the treatment of calcified plaque in conjunction with stenting in patients with coronary artery disease.

DAIC reaches 1 million pageviews using SEO and social media

May 23, 2017 — Diagnostic and Interventional Cardiology (DAIC) won the 2017 Azbee National Bronze Award and the Regional Bronze Award in the Online Best Use of Social Media category. DAIC used a combination of search engine optimization (SEO) and social media to increased its readership online by more than 300,000 page views in 2016 to reach more than 1 million page views in 2016.

Significant success has been achieved in treating complex proximal aneurysms using a combination of fenestrated and branched-graft devices, based on a report of prospectively studied patients with complex aortic aneurysm in the May edition of the Journal of Vascular Surgery.

The risk of heart transplant rejection can be reduced by desensitizing patient antibodies, according to research presented at Heart Failure 2017 and the 4th World Congress on Acute Heart Failure, April 29-May 2 in Paris, France. The breakthrough came on the 50th anniversary of heart transplantation.

Located along Mississippi’s Gulf Coast, Memorial Hospital at Gulfport is a nonprofit, 445-bed facility originally established in 1946. More than six decades later, it is the main cardiovascular and neurotrauma care provider in the region. To stay on top of a rapidly changing healthcare industry, the hospital uses the latest single-database McKesson Cardiology cardiovascular information system (CVIS) from Change Healthcare, bringing together its reporting from across all cardiac modalities.

 

Assessing Needs

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now